About: Polymorphisms in PARK2 and MRPL37 are associated with higher risk of recurrent venous thromboembolism in a sex-specific manner

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Polymorphisms in PARK2 and MRPL37 are associated with higher risk of recurrent venous thromboembolism in a sex-specific manner Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scholarly article by Kristina Sundquist et al published August 2018 in Journal of Thrombosis and Thrombolysis

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в серпні 2018 (uk) im August 2018 veröffentlichter wissenschaftlicher Artikel (de) scholarly article by Kristina Sundquist et al published August 2018 in Journal of Thrombosis and Thrombolysis (en)
publication date	wds:Q57172953-574CFC94-9C66-4C9E-B3C7-BC7A9A967FEC wds:Q57172953-DEE53E4F-7E14-47EF-8AF5-EDCC722FA974
publication date	2018-04-18 00:00:00Z (xsd:dateTime) 2018-08-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q57172953-C45E7D87-6ECB-4D4E-A74A-9EB365083491
language of work or name	English
exact match	wds:Q57172953-D62E6F3B-FF24-47C2-92D9-9A00CD500C1E
exact match	https://scigraph.springernature.com/pub.10.1007/s11239-018-1662-x
cites work	wds:Q57172953-04FFC598-9A9E-4BCE-BAAD-50C23FCFCF35 wds:Q57172953-05A1C873-1CBA-4557-A73C-C3BEBA7274A5 wds:Q57172953-0DD16216-93D9-46D1-A1E9-51100271A1ED wds:Q57172953-0E809856-A4EA-40C9-91F7-C2236D202426 wds:Q57172953-0F5D1FB1-2C61-43D2-9FFC-CE71548203DA wds:Q57172953-2E8099D5-DE39-4EA4-A125-8DC6539172B9 wds:Q57172953-334D989B-17F8-495F-9253-EA04B9B78E76 wds:Q57172953-378811E6-9E1E-4DBF-8F69-ADEA0CEADFAA wds:Q57172953-3E67258A-C90C-4AC7-A2EB-69D06F816D3F wds:Q57172953-4435D565-6FE5-4004-9297-785F089DC4F7 wds:Q57172953-468B8A0F-59C4-4647-A1CB-8049FBF459A0 wds:Q57172953-4C4A5FC3-8E40-4C00-9936-097FB300A76F wds:Q57172953-558D4DFE-ACD7-4AE8-823F-41D40A2E08A9 wds:Q57172953-605BA6FF-A0FA-4CF6-9FA5-83D2F89A5970 wds:Q57172953-6C6C3EDA-5056-4758-BB3F-A95032FB94F9 wds:Q57172953-6D70544B-C436-4B62-938D-63691F2DB8AF wds:Q57172953-70C9242F-B40F-454F-BF95-FD30296B8E82 wds:Q57172953-72A14E74-0237-45EF-8A28-9573D3C05CF3 wds:Q57172953-7356BBF8-3E99-4641-AF4B-74A56BB2E8E2 wds:Q57172953-74AD515E-2B86-4383-BD9D-6BF0B641018C wds:Q57172953-76396282-D05E-4915-BAEB-436829D95E2A wds:Q57172953-8800AC9F-CA2F-4BF7-B7C0-4A178736B209 wds:Q57172953-8846A722-8981-4632-B001-F5D16C29AC1A wds:Q57172953-88E30F73-F7C8-495C-B357-B23CF6390127 wds:Q57172953-8CBC8108-ED79-4F4C-A5B1-7767CCB1FA34 wds:Q57172953-8E76723E-0DC6-48E3-9655-2CE9AC3DEDE9 wds:Q57172953-94D6139F-6C3B-4D91-A5F5-0844927BD19D wds:Q57172953-9EB13BA3-51D4-4B85-BF9F-FDB85CB34077 wds:Q57172953-A2FACA90-9511-46BB-9B8D-F5C63C25A030 wds:Q57172953-A6114F11-33F3-4BA0-A6AD-F312AFB475AE wds:Q57172953-B4915821-BA8A-42DC-9AFA-0F2E698B5F3A wds:Q57172953-B6D6EC17-428A-408D-9ECA-63C208A88317 wds:Q57172953-BBF530B9-3786-4B43-BDA1-5443A032615F wds:Q57172953-BC2C3A5F-4F79-49EC-B2FF-AAD31F0F2787 wds:Q57172953-BD0FF959-AD24-4274-B0F6-A80F2A2963D2 wds:Q57172953-C42C8341-FDED-4416-8713-6F232C89B599 wds:Q57172953-CF9EEEB5-93E8-4BAE-81B9-81F259586A59 wds:Q57172953-D1512138-005B-436F-8926-A74EF0E37806 wds:Q57172953-D279F424-5D8C-479B-BD80-343C9B58D130 wds:Q57172953-E31569D5-C21E-48B5-9222-04D38CA8859B wds:Q57172953-E48326A8-E41E-476B-8282-18C2F8CF1DCC wds:Q57172953-E6F3E880-1A29-490F-BFC0-C0CB4D601A61 wds:Q57172953-ECE812C9-F87F-4080-AE36-B08D7066E6E8 wds:Q57172953-F0CA5D55-D967-4EE3-B39B-97FD81B0F1DB wds:Q57172953-F2039F35-5A2A-47AF-84C9-3D705A5514A6 wds:Q57172953-F6283F39-6BE1-4365-AC38-270FC4B05D43 wds:Q57172953-FC0716C2-5CAE-497E-9299-07ADC8CF8BD4 wds:Q57172953-FEC5E79F-FE4C-4C84-ABFC-13722B988265
cites work	Familial segregation of venous thromboembolism Risk assessment for recurrent venous thrombosis Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism Diseases of the mitochondrial DNA. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins Parkin protects mitochondrial genome integrity and supports mitochondrial DNA repair Oxidative stress and vascular disease Mitochondrial genomes: anything goes Mitochondrial dysfunction in cardiovascular disease Epidemiology of venous thromboembolism Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Free radicals, mitochondria, and oxidized lipids: the emerging role in signal transduction in vascular cells Proof of principle of potential clinical utility of multiple SNP analysis for prediction of recurrent venous thrombosis. Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review The risk of recurrent venous thromboembolism in men and women. The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C and protein S Genetics of Venous Thrombosis: update in 2015 Heparin cofactor activity measured with an amidolytic method Men had a higher risk of recurrent venous thromboembolism than women: a large population study Evaluation of recurrent venous thromboembolism in patients with Factor V Leiden mutation in heterozygous form. Smoking and risk of venous thromboembolism: a systematic review Past and future of genetic research in thrombosis The familial tendency in thrombo-embolic disease Prospective analysis of risk factors and distribution of venous thromboembolism in the population-based Malmö Thrombophilia Study (MATS). Thrombosis: a major contributor to global disease burden. Sex, age and normal post-anticoagulation D-dimer as risk factors for recurrence after idiopathic venous thromboembolism in the Prolong study extension Plasma levels of mitochondrial and nuclear DNA in patients with massive pulmonary embolism in the emergency department: a prospective cohort study. Differential risks in men and women for first and recurrent venous thrombosis: the role of genes and environment. Mitochondrial DNA alterations as a source of human disorders Mitochondrial diseases and the heart: an overview of molecular basis, diagnosis, treatment and clinical course Venous thromboembolism has the same risk factors as atherosclerosis: A PRISMA-compliant systemic review and meta-analysis Hypercholesterolemia as a risk factor for deep-vein thrombosis. Thrombomodulin gene c.1418C>T polymorphism and risk of recurrent venous thromboembolism Identification of Genetic Aberrations in Thrombomodulin Gene in Patients With Recurrent Venous Thromboembolism. A sibling based design to quantify genetic and shared environmental effects of venous thromboembolism in Sweden Risk of venous thrombosis in persons with increased body mass index and interactions with other genetic and acquired risk factors Systematic review of prognostic models for recurrent venous thromboembolism (VTE) post-treatment of first unprovoked VTE.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software